Want to join the conversation?
$DGX 2Q15 PR: Diluted earnings per share attributable to Quest Diagnostics' common stockholders was $0.81 compared to $0.92 in 2Q14. Adjusted diluted EPS excluding amortization expense was $1.25 compared to $1.19 in 2Q14. During 2Q15, company repurchased 0.6MM shares of its common stock at price of $72.03 per share for $39MM.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.